Healthcare, Pharma & Life Sciences

Halozyme Names Ex-Incyte Commercial Chief Jim Daly to Board

Image
Halozyme Names Ex-Incyte Commercial Chief Jim Daly to Board

San Diego – October 01, 2026 -- Halozyme Therapeutics (Nasdaq: HALO) has appointed James "Jim" Daly to its Board of Directors, returning a veteran biopharmaceutical commercial executive to help steer the company's drug-delivery technology expansion.

Daly rejoins board after prior tenure, bringing three decades of launch experience

Daly previously served on Halozyme's board and has held senior commercial leadership roles at Incyte Corporation, Amgen and Glaxo Wellcome/GlaxoSmithKline. He was Executive Vice President and Chief Commercial Officer of Incyte from 2012 to 2015, following a decade at Amgen where he most recently served as Senior Vice President, North America Commercial Operations, Global Marketing and Commercial Development. Earlier, he spent more than 16 years at Glaxo Wellcome/GlaxoSmithKline, including as Senior Vice President and General Manager of the U.S. respiratory business.

Haemonetics to Report Fiscal Q2 2027 Results on Nov. 5

Image
Haemonetics to Report Fiscal Q2 2027 Results on Nov. 5

Boston – October 01, 2026 -- Haemonetics Corporation (NYSE: HAE) will publish its second quarter fiscal year 2027 financial results at 6:00 am ET on Thursday, October 01, 2026.

Haemonetics sets investor call for 8:00 am ET on November 5

The medical technology company will hold a conference call with investors and analysts two hours after the earnings release to discuss results and answer questions. Participants can access the call via teleconference after completing registration, which provides a dial-in number and personalized PIN.

Live webcast replay to remain available for one year

A live webcast of the call will be accessible on Haemonetics' investor relations website. The company will maintain a replay of the conference call and webcast for one year beginning October 01, 2026 at 11:00 am ET, using the same webcast link.

Midmark RTLS Adds Staff Duress Alerts to Epic Toolbox

Image
Midmark RTLS Adds Staff Duress Alerts to Epic Toolbox

Versailles, Ohio – October 01, 2026 -- Midmark RTLS has added its CareFlow RTLS Staff Duress solution to the Epic Toolbox in the Staff Duress category for 2026, integrating real-time, location-aware caregiver duress alerts directly into Epic's electronic health record system.

Badge-based alerts feed directly into Epic's push notification framework

CareFlow Staff Duress connects to Epic using HL7 FHIR-based APIs, allowing Midmark RTLS badges already worn by caregivers to trigger duress alerts with a discreet button press. When activated, Epic receives the staff member's identity and real-time location and notifies designated security and informational response groups through its push notification system. Responders can acknowledge or decline alerts within Epic itself, keeping emergency coordination inside existing clinical software.

Taejoon Ahn Named CEO of Washington Permanente Medical Group

Image
Taejoon Ahn Named CEO of Washington Permanente Medical Group

Seattle – October 01, 2026 -- Washington Permanente Medical Group (WPMG) has named Taejoon Ahn, MD, MPH, as its new CEO and executive medical director, placing him at the head of an organization that oversees more than 1,200 clinicians serving over 550,000 Kaiser Permanente members across Washington state.

Ahn succeeds interim leader Dorian Reid, who held the role since September 2025

Dr. Ahn takes over an independent, physician-owned medical group that works exclusively with Kaiser Permanente to deliver care in the region. The leadership transition closes a one-year interim period under Dorian Reid, MD.

Boston Globe Media, Tufts Health Plan Launch Season 6 of 'Turning Points'

Boston – September 30, 2026 -- Boston Globe Media and Tufts Health Plan have renewed their branded content partnership for a sixth season of "Turning Points: Navigating Mental Health," a five-episode podcast series debuting new installments every Wednesday starting October 7, 2026.

Studio/B produces the series as branded content separate from newsroom operations

The podcast is created by Boston Globe Media's branded content division, Studio/B, in collaboration with Tufts Health Plan, a Point32Health company. The Boston Globe's news and editorial departments have no role in the production, the companies confirmed.

Season six tackles parenting, loss and news-cycle anxiety

The new season addresses parenting in the age of social media, starting over after loss, and managing mental health amid a constant news cycle. Clinical social worker Frantzes Lys returns as host, interviewing guests about personal mental health turning points.

HCTI Signs MOU for 70% Stake in Humanoid Nursing Robot JV

Pleasanton, Calif. – – September 30, 2026 -- Healthcare Triangle, Inc. (Nasdaq: HCTI) has signed a Memorandum of Understanding with Malaysia's AI World Sdn. Bhd. to form a joint venture deploying AI-enabled humanoid nursing robots across North American hospitals, with HCTI taking a 70% ownership stake against AI World's 30%.

Joint venture targets toileting and hygiene care, among the most physically demanding nursing tasks

The proposed venture would hold intellectual property and distribution rights for the robots in North America. The machines are designed to assist with patient toileting and related cleaning and hygiene work under clinical supervision, tasks HCTI says are both physically taxing for staff and sensitive for patients.

Upsher-Smith Launches Generic Fluvoxamine ER, Targets $44.6M US Market

Image
Upsher-Smith Launches Generic Fluvoxamine ER, Targets $44.6M US Market

Maple Grove, Minn. – September 30, 2026 -- Upsher-Smith Laboratories, LLC has launched Fluvoxamine Maleate Extended-Release Capsules in 100 mg and 150 mg strengths, entering a U.S. market valued at approximately $44.6 million according to IQVIA data covering August 2025 through July 2026.

Upsher-Smith secures AB-rated status against branded Luvox CR

The product carries a Therapeutic Equivalence (TE) code of AB, with Luvox CR designated as the Reference Listed Drug. The AB rating allows the generic to be considered therapeutically equivalent and substitutable for the brand-name extended-release formulation in U.S. pharmacy channels.

NYU Langone AI Tool Closes Radiology Training Gaps With 90% Accuracy

Image
NYU Langone AI Tool Closes Radiology Training Gaps With 90% Accuracy

New York – September 30, 2026 -- Researchers at NYU Langone Health have built an artificial intelligence system that tracks the daily case exposure of radiology residents and flags missing pathologies with more than 90 percent accuracy, according to a study published online in Academic Radiology.

AI system pinpoints training gaps that traditional case logs miss

The tool monitors which conditions residents encounter during clinical rotations and automatically identifies underexposed pathologies, then assigns supplemental teaching cases to close the gap. Study author Vinay Prabhu, an associate professor in NYU Grossman School of Medicine's Department of Radiology, said residents seeing 30 cases in a day typically encounter 29 routine exams and only one uncommon condition, leaving gaps in exposure to rarer diseases they will face throughout their careers.

LateralCare's Revenue Alai AI Platform Launches on Microsoft Marketplace

Image
LateralCare's Revenue Alai AI Platform Launches on Microsoft Marketplace

Dallas – September 30, 2026 -- LateralCare has made its flagship revenue cycle management platform, revenue alai, available on Microsoft Marketplace, giving healthcare organizations worldwide direct access to deploy the Agentic AI solution within existing Azure environments.

Microsoft Marketplace listing enables direct deployment within Azure ecosystems

Customers can now discover and deploy revenue alai through Microsoft Marketplace, the unified platform for cloud solutions, AI apps, and agents. The listing allows streamlined management and integration across Microsoft Azure and other Microsoft products, reducing procurement friction for healthcare systems already operating on Microsoft infrastructure.

ProgenyHealth Names Melanie Bella to Board, Alec DiDonato as COO

Image
ProgenyHealth Names Melanie Bella to Board, Alec DiDonato as COO

UNITED STATES – September 30, 2026 -- ProgenyHealth has appointed Melanie Bella to its Board of Managers and named Alec DiDonato as Chief Operating Officer, moves the maternity and NICU care management company says will support its national expansion.

Bella brings 25 years of Medicaid policy experience to the board

Bella, an Executive Advisor with Cressey & Company, previously chaired the Medicaid and CHIP Payment and Access Commission (MACPAC). She served as Executive Vice President of Policy and Duals Strategy at Cityblock Health, a value-based provider focused on Medicaid and dual-eligible populations, and was the first Director of the Medicare-Medicaid Coordination Office at the Centers for Medicare & Medicaid Services. She also served as Medicaid Director for the state of Indiana and holds an MBA from Harvard Business School and a bachelor's degree from DePauw University.